Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

October 30, 2019

Study Completion Date

October 30, 2019

Conditions
Cartilage Diseases
Interventions
BIOLOGICAL

NOVOCART 3D

Autologous Chondrocyte Implantation

Trial Locations (9)

24106

Lubinus Clinicum, Kiel

30171

Diakoniekrankenhaus Henriettenstiftung gGmbH, Hanover

68165

Theresienkrankenhaus, Mannheim

69118

Heidelberg University Hospital, Heidelberg

79194

Gelenk Klinik Orthopaedic Clinic, Gundelfingen

81377

Department of Orthopedic Surgery and the Department of Physical Medicine and Rehabilitation LMU Munich, Munich

81675

Klinik rechts der Isar, München

93053

University Hospital Regensburg, Regensburg

98049

Sozialstiftung Bamberg, Klinikum am Bruderwald, Bamberg

All Listed Sponsors
collaborator

Aesculap AG

INDUSTRY

lead

Tetec AG

INDUSTRY

NCT02348697 - Non-Interventional Study to Evaluate Safety and Efficacy of NOVOCART 3D in Patients With Cartilage Defects | Biotech Hunter | Biotech Hunter